Efficacy of low-level laser therapy on pain and disability in knee osteoarthritis: systematic review and meta-analysis of randomized placebo-controlled trials.
Approximately 13% of women and 10% of men in the population aged ≥60 years suffer from knee osteoarthritis (KOA) in the USA. NSAIDs, despite the intake of these drugs being associated with negative side effects, which is problematic, are recommended in most KOA clinical treatment guidelines and is probably the most frequently prescribed therapy category for osteoarthritis.
LLLT is a non-invasive treatment modality, which has been reported to induce anti-inflammatory effects.
No pain. All gain.
Patented and FDA-cleared MLS® Laser Therapy technology provides…
- Effective treatment of painful and debilitating conditions
- 85%-90% efficacy rate
- No risk from surgery or prescription painkillers
- A cash-based modality to generate revenue for your practice
Learn More about the benefits of MLS Laser Therapy.
